SAN DIEGO, Feb. 8, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences in February:
| |||
Date: | Tuesday, February 15, 2011 | ||
Time: | 9:00am Eastern Time (6:00am Pacific Time) | ||
Place: | Waldorf Astoria Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
| |||
Date: | Thursday, February 17, 2011 | ||
Time: | 10:05am Eastern Time (7:05am Pacific Time) | ||
Place: | Roosevelt Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 | |
SOURCE Cadence Pharmaceuticals, Inc.
